Related Experiment Video
Updated: Jul 18, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Bipolar II disorder: current and future treatment options
Rif El-Mallakh1, Richard H Weisler, Mark H Townsend
1Dept. of Psychiatry, University of Louisville School of Medicine, Louisville, KY 40202, USA. rselma01@louisville.edu
Summary
Bipolar II disorder treatment is challenging due to recurrent depression. Lithium, carbamazepine, and quetiapine show efficacy, with quetiapine FDA-approved for bipolar depression.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Bipolar II disorder presents significant public health challenges in the US.
- Effective treatments for recurrent major depressive episodes in BPII are limited.
- This review synthesizes data on therapeutic agents for BPII.
Purpose of the Study:
- To review available data on agents for treating Bipolar II disorder.
- To summarize efficacy of treatments for major depressive episodes in BPII.
Main Methods:
- Systematic review of English language controlled clinical trials.
- Extensive Medline search for relevant BPII patient studies.
Main Results:
- Efficacy of potential BPII treatment agents is profiled.
- Data is based on studies of bipolar I or unipolar depression.
Conclusions:
- Agents with bimodal stabilizing properties like lithium, carbamazepine, and quetiapine are most effective.
- Quetiapine is the first FDA-approved monotherapy for bipolar depression, including BPII.
- Lamotrigine also demonstrates promise for BPII treatment.
Related Concept Videos
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...